Latest Connective tissue diseases Stories
ACR supports best practices for ultrasonography use in rheumatology More rheumatologists are embracing musculoskeletal ultrasound (MSUS) to diagnose and manage rheumatic diseases. In response, the American College of Rheumatology (ACR) assembled a task force to investigate and determine best practices for use of MSUS in rheumatology practice. The resulting scenario-based recommendations, which aim to help clinicians understand when it is reasonable to integrate MSUS into their rheumatology...
BRISBANE, Calif., Oct. 23, 2012 /PRNewswire/ -- SARcode Bioscience, Inc., announced topline results from OPUS-1, a pivotal Phase 3 study of lifitegrast ophthalmic solution, 5.0%, versus placebo for the treatment of dry eye disease. In the study, which included 588 subjects, lifitegrast demonstrated superiority over placebo in the improvement of inferior and total corneal staining scores from baseline to week 12 (P=0.0007 and P=0.0148, respectively). Ocular surface damage, which is...
Educational Conference on October 20 in Long Beach, California, Helps Young Adults with Arthritis, the Leading Cause of Disability in the United States LOS ANGELES, Oct 12, 2012 /PRNewswire-USNewswire/ -- The Arthritis Foundation is sponsoring the 3(rd) Annual PrimeTime symposium (formerly Arthritis in PrimeTime) on Saturday, October 20 at the Long Beach Renaissance Hotel in Long Beach, California. This premier educational and motivational event fosters active, productive and...
Support for People in Nebraska, Iowa and Eastern South Dakota DANVERS, Mass., Sept. 28, 2012 /PRNewswire-USNewswire/ -- The Scleroderma Foundation announced today that it has chartered a new chapter to help people living with scleroderma in the states of Iowa, Nebraska and eastern South Dakota. This means more support for individuals with the debilitating autoimmune illness in the central United States. The Scleroderma Foundation, Heartland Chapter is the Foundation's 24th chapter....
Arthritis Alliance of Canada Launches Framework for Improved Policies and Practices CALGARY, Sept. 18, 2012 /CNW/ - A nationwide coalition of more than thirty groups including patients, health care providers, researchers, care organizations and industry partners today called upon Canadians to designate improved arthritis prevention and care as an urgent national priority. The Arthritis Alliance of Canada (AAC) outlined a plan to address this critical issue facing the country...
ANAHEIM, Calif., Sept. 13, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that the company will be teaming up with The Myositis Association (TMA) to support research and educational initiatives in dermatomyositis and polymyositis. "Questcor is very pleased to be able to make this commitment to The Myositis Association and the dermatomyositis and polymyositis communities," said Steve Cartt, Chief Operating Officer of Questcor. "Further research into...
BALTIMORE, Sept. 12, 2012 /PRNewswire/ -- Gliknik Inc., a biopharmaceuticals company creating new therapies for cancer and immune / inflammatory disorders, today announced that its stradomers(TM) have clinical therapeutic potential, based upon newly published preclinical data in models of rheumatoid arthritis and thrombocytopenia (blood platelet deficiency). The research, which is part of a collaboration with the lab of Professor Scott Strome at the University of Maryland,...
Tokyo, Sept 11, 2012 - (JCN Newswire) - Eisai Co., Ltd. announced today that it will launch the anti-rheumatic agent Careram(R) (iguratimod) in Japan on September 12 for the treatment of rheumatoid arthritis. Careram, jointly developed in Japan by Eisai and Toyama Chemical Co., Ltd. from the Phase III clinical development stage, was approved by Japan's Ministry of Health, Labour and Welfare (MHLW) in June of this year and was subsequently listed on the National...
redOrbit Staff & Wire Reports – Your Universe Online A Massachusetts-based bio-pharmaceutical company is developing a new treatment for autoimmune diseases from a parasite found in pig feces, Reuters writer Toni Clarke reported on Friday. Coronado Biosciences, based in the town of Burlington, is currently working on a new drug consisting of thousands of microscopic parasite eggs removed from the droppings of the large-snouted, hoofed mammals, Clarke said. The eggs are suspended...
The research relates to a family of molecules firstly discovered in Melbourne that applied to blood cell development. One of these, granulocyte macrophage colony-stimulating factor or GM-CSF, acts as a messenger between cells acting at a site of inflammation. Professor John Hamilton has posed the question: could blocking GM-CSF action lead to a new treatment for inflammatory diseases? In experimental models of rheumatoid arthritis, Professor Hamilton and Dr Andrew Cook had previously shown...
